Trial site
Children's Hospital, Zhejiang University School of Medicine
- 30running trials
- 5closed trials
The trials here
What the 36 trials at this site are about, from their registry records.
- Conditions
- Nephrotic syndrome8 trials
- Childhood cancers6 trials
- Systemic sclerosis (scleroderma)6 trials
- Lupus (SLE)5 trials
- Haemophilia4 trials
- IgA nephropathy4 trials
- Acute myeloid leukaemia3 trials
- Dermatomyositis and polymyositis (myositis)3 trials
- Acute lymphoblastic leukaemia2 trials
- ANCA-associated vasculitis2 trials
- Congenital heart disease2 trials
- Fabry disease2 trials
- and 4 more
- Phase
- Phase 311 trials
- Phase 18 trials
- Early phase 13 trials
- Phase 23 trials
- Phase 1/22 trials
- Phase 41 trial
- Status
- Recruiting18 trials
- Not yet recruiting10 trials
- Completed4 trials
- Active, not recruiting2 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- The Children's Hospital of Zhejiang University School of Medicine17 trials
- Chongqing Precision Biotech Co., Ltd3 trials
- Mao Jianhua3 trials
- Novo Nordisk A/S3 trials
- Nanjing Zenshine Pharmaceuticals2 trials
- and 8 more
Running trials
Not yet recruiting
Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A
Not yet recruiting
A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents
Recruiting
Not yet recruiting
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery
Recruiting
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
Not yet recruiting
Effect of High-Flow Nasal Cannula Oxygen Therapy on Hypoxemia in Pediatric Sedated Bronchoscopy
Not yet recruiting
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
Recruiting
Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors
Recruiting
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Recruiting
Immune Profiling of Refractory cSLE Exposed to CD3×CD19 BiTE
Recruiting
Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Recruiting
Not yet recruiting
The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease
Recruiting
Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus
Recruiting
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
Recruiting
Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease
Recruiting
Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China
Recruiting
Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS
Recruiting
Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis
Active, not recruiting
Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus
Active, not recruiting
Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Nephrotic syndrome8 recruiting
- Childhood cancers5 recruiting
- Systemic sclerosis (scleroderma)5 recruiting
- IgA nephropathy4 recruiting
- Lupus (SLE)4 recruiting
- Dermatomyositis and polymyositis (myositis)3 recruiting
- Acute lymphoblastic leukaemia2 recruiting
- Acute myeloid leukaemia2 recruiting
- ANCA-associated vasculitis2 recruiting
- Congenital heart disease2 recruiting
- Fabry disease2 recruiting
- Haemophilia1 recruiting
- Obesity1 recruiting
- Spinal muscular atrophy1 recruiting
- Ulcerative colitis1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Terminated
Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza
Completed
Completed
A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026